Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy.

Toiyama Y, Oki S, Okugawa Y, Ide S, Yasuda H, Fujikawa H, Yoshiyama S, Hiro J, Ohi M, Inoue Y, Araki T, Kusunoki M.

Oncology. 2018 Jul 11:1-11. doi: 10.1159/000490149. [Epub ahead of print]

PMID:
29996133
2.

Laparoscopic diagnosis of retrograde peristalsis and intussusception in Roux-en-Y limb after laparoscopic gastrectomy: A case report.

Yoshiyama S, Toiyama Y, Ichikawa T, Shimura T, Yasuda H, Hiro JI, Ohi M, Araki T, Kusunoki M.

Asian J Endosc Surg. 2018 Jun 5. doi: 10.1111/ases.12611. [Epub ahead of print]

PMID:
29871028
3.

Feasibility of Assessing Prognostic Nutrition Index in Patients With Rectal Cancer Who Receive Preoperative Chemoradiotherapy.

Okugawa Y, Toiyama Y, Oki S, Ide S, Yamamoto A, Ichikawa T, Kitajima T, Fujikawa H, Yasuda H, Saigusa S, Hiro J, Yoshiyama S, Kobayashi M, Araki T, Kusunoki M.

JPEN J Parenter Enteral Nutr. 2018 Jan 7. doi: 10.1002/jpen.1041. [Epub ahead of print]

PMID:
29786882
4.

Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.

Okugawa Y, Toiyama Y, Yamamoto A, Shigemori T, Yin C, Narumi A, Omura Y, Ide S, Kitajima T, Fujikawa H, Yasuda H, Hiro J, Yoshiyama S, Kobayashi M, Araki T, McMillan DC, Miki C, Kusunoki M.

JPEN J Parenter Enteral Nutr. 2018 May 15. doi: 10.1002/jpen.1171. [Epub ahead of print]

PMID:
29761898
5.

Clinical Burden of Modified Glasgow Prognostic Scale in Colorectal Cancer.

Okugawa Y, Shirai Y, Toiyama Y, Saigusa S, Hishida A, Yokoe T, Tanaka K, Tanaka M, Yasuda H, Fujikawa H, Hiro J, Kobayashi M, Araki T, Inoue Y, McMillan DC, Kusunoki M, Miki C.

Anticancer Res. 2018 Mar;38(3):1599-1610.

PMID:
29491091
6.

Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients.

Okugawa Y, Yao L, Toiyama Y, Yamamoto A, Shigemori T, Yin C, Omura Y, Ide S, Kitajima T, Shimura T, Fujikawa H, Yasuda H, Hiro J, Yoshiyama S, Kobayashi M, Tanaka K, Inoue Y, Araki T, Miki C, Kusunoki M.

Oncol Rep. 2018 Apr;39(4):1555-1564. doi: 10.3892/or.2018.6270. Epub 2018 Feb 14.

PMID:
29484416
7.

Successful identification of a predictive biomarker for lymph node metastasis in colorectal cancer using a proteomic approach.

Mori K, Toiyama Y, Otake K, Ide S, Imaoka H, Okigami M, Okugawa Y, Fujikawa H, Saigusa S, Hiro J, Kobayashi M, Ohi M, Tanaka K, Inoue Y, Kobayashi Y, Mohri Y, Kobayashi I, Goel A, Kusunoki M.

Oncotarget. 2017 Oct 30;8(63):106935-106947. doi: 10.18632/oncotarget.22149. eCollection 2017 Dec 5.

8.

Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.

Ide S, Toiyama Y, Okugawa Y, Oki S, Yasuda H, Fujikawa H, Yoshiyama S, Hiro J, Kobayashi M, Ohi M, Araki T, Kusunoki M.

Anticancer Res. 2017 Oct;37(10):5797-5804.

PMID:
28982904
9.

Laparoscopic ileopexy for afferent limb syndrome after ileal pouch-anal anastomosis.

Okita Y, Araki T, Hiro J, Kondo S, Fujikawa H, Yoshiyama S, Inoue M, Toiyama Y, Kobayashi M, Ohi M, Inoue Y, Uchida K, Mohri Y, Kusunoki M.

Asian J Endosc Surg. 2017 Nov;10(4):424-426. doi: 10.1111/ases.12386. Epub 2017 Jun 30.

PMID:
28664652
10.

Clinical burden of preoperative albumin-globulin ratio in esophageal cancer patients.

Oki S, Toiyama Y, Okugawa Y, Shimura T, Okigami M, Yasuda H, Fujikawa H, Okita Y, Yoshiyama S, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Mohri Y, Kusunoki M.

Am J Surg. 2017 Nov;214(5):891-898. doi: 10.1016/j.amjsurg.2017.04.007. Epub 2017 Apr 25.

PMID:
28460738
11.

Prognostic Impact of Preoperative Albumin-to-Globulin Ratio in Patients with Colon Cancer Undergoing Surgery with Curative Intent.

Fujikawa H, Toiyama Y, Inoue Y, Imaoka H, Shimura T, Okigami M, Yasuda H, Hiro J, Yoshiyama S, Saigusa S, Kobayashi M, Ohi M, Araki T, Mohri Y, Kusunoki M.

Anticancer Res. 2017 Mar;37(3):1335-1342.

PMID:
28314300
12.

Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.

Shimura T, Toiyama Y, Saigusa S, Imaoka H, Okigami M, Fujikawa H, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Uchida K, Mohri Y, Kusunoki M.

Int J Clin Oncol. 2017 Aug;22(4):758-766. doi: 10.1007/s10147-017-1113-2. Epub 2017 Mar 15.

PMID:
28299463
13.

Modified Martius flap procedure for refractory ileal pouch-vestibular fistula: a report of three cases.

Araki T, Okita Y, Kawamura M, Kondo S, Toiyama Y, Hiro J, Yoshiyama S, Uchida K, Kusunoki M.

Int J Colorectal Dis. 2017 May;32(5):757-759. doi: 10.1007/s00384-016-2746-8. Epub 2016 Dec 29.

PMID:
28035458
14.

Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.

Mori K, Toiyama Y, Otake K, Fujikawa H, Saigusa S, Hiro J, Kobayashi M, Ohi M, Tanaka K, Inoue Y, Kobayashi Y, Kobayashi I, Mohri Y, Goel A, Kusunoki M.

Int J Cancer. 2017 Mar 15;140(6):1425-1435. doi: 10.1002/ijc.30557.

15.

MicroRNA-7 Is Associated with Malignant Potential and Poor Prognosis in Human Colorectal Cancer.

Nagano Y, Toiyama Y, Okugawa Y, Imaoka H, Fujikawa H, Yasuda H, Yoshiyama S, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Mohri Y, Kusunoki M.

Anticancer Res. 2016 Dec;36(12):6521-6526.

PMID:
27919977
16.

Clinical Burden of C-Reactive Protein/Albumin Ratio Before Curative Surgery for Patients with Gastric Cancer.

Toiyama Y, Shimura T, Yasuda H, Fujikawa H, Okita Y, Kobayashi M, Ohi M, Yoshiyama S, Hiro J, Araki T, Inoue Y, Mohri Y, Kusunoki M.

Anticancer Res. 2016 Dec;36(12):6491-6498.

PMID:
27919972
17.

Clinical Characteristics of Stoma-Related Obstruction after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.

Okita Y, Araki T, Kondo S, Fujikawa H, Yoshiyama S, Hiro J, Inoue M, Toiyama Y, Kobayashi M, Ohi M, Inoue Y, Uchida K, Mohri Y, Kusunoki M.

J Gastrointest Surg. 2017 Mar;21(3):554-559. doi: 10.1007/s11605-016-3329-2. Epub 2016 Nov 28.

PMID:
27896653
18.

Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.

Uratani R, Toiyama Y, Kitajima T, Kawamura M, Hiro J, Kobayashi M, Tanaka K, Inoue Y, Mohri Y, Mori T, Kato T, Goel A, Kusunoki M.

PLoS One. 2016 Oct 19;11(10):e0160722. doi: 10.1371/journal.pone.0160722. eCollection 2016.

19.

Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.

Imaoka H, Toiyama Y, Fujikawa H, Hiro J, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Mori T, Kato T, Toden S, Goel A, Kusunoki M.

Ann Oncol. 2016 Oct;27(10):1879-86. doi: 10.1093/annonc/mdw279. Epub 2016 Aug 8.

PMID:
27502702
20.

Monitoring perioperative serum albumin can identify anastomotic leakage in colorectal cancer patients with curative intent.

Shimura T, Toiyama Y, Hiro J, Imaoka H, Fujikawa H, Kobayashi M, Ohi M, Inoue Y, Mohri Y, Kusunoki M.

Asian J Surg. 2018 Jan;41(1):30-38. doi: 10.1016/j.asjsur.2016.07.009. Epub 2016 Jul 19.

21.

The impact of body mass index on oncological outcomes in colorectal cancer patients with curative intent.

Toiyama Y, Hiro J, Shimura T, Fujikawa H, Ohi M, Tanaka K, Inoue Y, Mohri Y, Kusunoki M.

Int J Clin Oncol. 2016 Dec;21(6):1102-1110. Epub 2016 Jul 11.

PMID:
27402104
22.

Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer.

Okugawa Y, Toiyama Y, Mohri Y, Tanaka K, Kawamura M, Hiro J, Araki T, Inoue Y, Miki C, Kusunoki M.

J Surg Oncol. 2016 Sep;114(4):483-9. doi: 10.1002/jso.24335. Epub 2016 Jun 28.

PMID:
27349356
23.

Clinical significance of enlarged lateral pelvic lymph nodes before and after preoperative chemoradiotherapy for rectal cancer.

Inoue Y, Saigusa S, Hiro J, Toiyama Y, Araki T, Tanaka K, Mohri Y, Kusunoki M.

Mol Clin Oncol. 2016 Jun;4(6):994-1002. Epub 2016 Apr 8.

24.

Impact of sarcopenia on surgical site infection after restorative proctocolectomy for ulcerative colitis.

Fujikawa H, Araki T, Okita Y, Kondo S, Kawamura M, Hiro J, Toiyama Y, Kobayashi M, Tanaka K, Inoue Y, Mohri Y, Uchida K, Kusunoki M.

Surg Today. 2017 Jan;47(1):92-98. Epub 2016 Jun 2.

PMID:
27255541
25.

miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.

Noguchi T, Toiyama Y, Kitajima T, Imaoka H, Hiro J, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Toden S, Kusunoki M.

Oncology. 2016;90(4):221-31. doi: 10.1159/000444493. Epub 2016 Mar 22.

PMID:
26999740
26.

Exacerbation of Dermatomyositis with Recurrence of Rectal Cancer: A Case Report.

Nagano Y, Inoue Y, Shimura T, Fujikawa H, Okugawa Y, Hiro J, Toiyama Y, Tanaka K, Mohri Y, Kusunoki M.

Case Rep Oncol. 2015 Nov 10;8(3):482-6. doi: 10.1159/000439519. eCollection 2015 Sep-Dec.

27.

Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer.

Uratani R, Toiyama Y, Shimura T, Mori K, Fujikawa H, Hiro J, Ohi M, Inoue Y, Tanaka K, Araki T, Mohri Y, Kusunoki M.

Anticancer Res. 2015 Oct;35(10):5639-48.

PMID:
26408737
28.

Efficacy and safety of laparoscopic surgery in elderly patients with colorectal cancer.

Inoue Y, Kawamoto A, Okugawa Y, Hiro J, Saigusa S, Toiyama Y, Araki T, Tanaka K, Mohri Y, Kusunoki M.

Mol Clin Oncol. 2015 Jul;3(4):897-901. Epub 2015 Mar 30.

29.

Serum Angiopoietin-like Protein 2 Improves Preoperative Detection of Lymph Node Metastasis in Colorectal Cancer.

Toiyama Y, Inoue Y, Shimura T, Fujikawa H, Saigusa S, Hiro J, Kobayashi M, Ohi M, Araki T, Tanaka K, Mohri Y, Kusunoki M.

Anticancer Res. 2015 May;35(5):2849-56.

PMID:
25964566
30.

Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery.

Mori K, Toiyama Y, Saigusa S, Fujikawa H, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Tanaka K, Mohri Y, Kusunoki M.

Dig Dis Sci. 2015 Aug;60(8):2477-87. doi: 10.1007/s10620-015-3648-2. Epub 2015 Apr 4.

PMID:
25840921
31.

Systemic Acute-phase Response in Laparoscopic and Open Ileal Pouch Anal Anastomosis in Patients With Ulcerative Colitis: A Case-matched Comparative Study.

Okita Y, Araki T, Hiro J, Ide S, Imaoka H, Kondo S, Kawamura M, Fujikawa H, Inoue M, Toiyama Y, Ohi M, Tanaka K, Inoue Y, Uchida K, Mohri Y, Kusunoki M.

Surg Laparosc Endosc Percutan Tech. 2015 Oct;25(5):424-9. doi: 10.1097/SLE.0000000000000128.

PMID:
25730740
32.

Preoperative assessment of vascular anatomy by multidetector computed tomography before laparoscopic colectomy for transverse colon cancer: report of a case.

Kawamoto A, Inoue Y, Okigami M, Yasuda H, Okugawa Y, Hiro J, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Kusunoki M.

Int Surg. 2015 Feb;100(2):208-12. doi: 10.9738/INTSURG-D-13-00232.1.

33.

Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery.

Toiyama Y, Inoue Y, Kawamura M, Kawamoto A, Okugawa Y, Hiro J, Saigusa S, Tanaka K, Mohri Y, Kusunoki M.

Int Surg. 2015 Feb;100(2):199-207. doi: 10.9738/INTSURG-D-13-00178.1.

34.

Comparison of reduced-port and conventional laparoscopic total proctocolectomy with ileal J-pouch-anal anastomosis.

Inoue Y, Hiro J, Kawamoto A, Okugawa Y, Okita Y, Toiyama Y, Araki T, Tanaka K, Mohri Y, Kusunoki M.

Am Surg. 2015 Feb;81(2):E70-2. No abstract available.

PMID:
25642861
35.

RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.

Imaoka H, Toiyama Y, Saigusa S, Kawamura M, Kawamoto A, Okugawa Y, Hiro J, Tanaka K, Inoue Y, Mohri Y, Kusunoki M.

Carcinogenesis. 2015 Mar;36(3):346-54. doi: 10.1093/carcin/bgu327. Epub 2015 Jan 7.

PMID:
25568185
36.

Conversion Therapy Using mFOLFOX6 With Panitumumab for Unresectable Liver Metastases From Multiple Colorectal Cancers With Familial Adenomatous Polyposis.

Toiyama Y, Inoue Y, Kitajima T, Okigami M, Kawamura M, Kawamoto A, Okugawa Y, Hiro J, Tanaka K, Mohri Y, Kusunoki M.

Int Surg. 2014 Nov-Dec;99(6):795-801. doi: 10.9738/INTSURG-D-13-00125.1.

37.

Puborectal sling interposition combined with seton drainage for pouch-vaginal fistula after rectal cancer surgery with colonic J pouch-anal reconstruction: report of a case.

Kawamoto A, Inoue Y, Okigami M, Okugawa Y, Hiro J, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Kusunoki M.

Int Surg. 2014 Nov-Dec;99(6):710-3. doi: 10.9738/INTSURG-D-13-00187.1.

38.

Sphincter-saving resection of rectal hemangioma based on Doppler transrectal ultrasonography findings: report of a case.

Fujikawa H, Araki T, Hashimoto K, Okita Y, Tanaka K, Hiro J, Inoue Y, Mohri Y, Uchida K, Kusunoki M.

Int Surg. 2014 Nov-Dec;99(6):705-9. doi: 10.9738/INTSURG-D-13-00084.1.

39.

Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence.

Toiyama Y, Tanaka K, Kitajima T, Shimura T, Kawamura M, Kawamoto A, Okugawa Y, Saigusa S, Hiro J, Inoue Y, Mohri Y, Goel A, Kusunoki M.

Clin Cancer Res. 2014 Dec 1;20(23):6175-86. doi: 10.1158/1078-0432.CCR-14-0007. Epub 2014 Oct 7.

40.

Phase I study of 5-fluorouracil, leucovorin and bevacizumab in combination with radiation therapy in patients with locally advanced rectal cancer.

Inoue Y, Okigami M, Kawamoto A, Okugawa Y, Hiro J, Saigusa S, Toiyama Y, Tanaka K, Mohri Y, Kusunoki M.

Mol Clin Oncol. 2013 May;1(3):511-516. Epub 2013 Feb 20.

41.

C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.

Toiyama Y, Inoue Y, Saigusa S, Kawamura M, Kawamoto A, Okugawa Y, Hiro J, Tanaka K, Mohri Y, Kusunoki M.

Anticancer Res. 2013 Nov;33(11):5065-74.

PMID:
24222151
42.

Multimodality therapy in fistula-associated perianal mucinous adenocarcinoma.

Inoue Y, Kawamoto A, Okigami M, Okugawa Y, Hiro J, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Kusunoki M.

Am Surg. 2013 Sep;79(9):e286-8. No abstract available.

PMID:
24069962
43.

Single-port laparoscopic management of adhesive small bowel obstruction.

Hiro J, Inoue Y, Okugawa Y, Kawamoto A, Okita Y, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Kusunoki M.

Surg Today. 2014 Mar;44(3):586-90. doi: 10.1007/s00595-013-0729-8. Epub 2013 Sep 19.

PMID:
24048766
44.

Prognostic nutritional index predicts postoperative outcome in colorectal cancer.

Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M.

World J Surg. 2013 Nov;37(11):2688-92. doi: 10.1007/s00268-013-2156-9.

PMID:
23884382
45.

Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.

Okugawa Y, Inoue Y, Tanaka K, Toiyama Y, Shimura T, Okigami M, Kawamoto A, Hiro J, Saigusa S, Mohri Y, Uchida K, Kusunoki M.

Oncol Rep. 2013 Sep;30(3):1449-54. doi: 10.3892/or.2013.2558. Epub 2013 Jun 20.

PMID:
23784200
46.

Decreased expression of DUSP4 is associated with liver and lung metastases in colorectal cancer.

Saigusa S, Inoue Y, Tanaka K, Toiyama Y, Okugawa Y, Shimura T, Hiro J, Uchida K, Mohri Y, Kusunoki M.

Med Oncol. 2013;30(3):620. doi: 10.1007/s12032-013-0620-x. Epub 2013 Jun 8.

PMID:
23749251
47.

Chemoradiotherapy followed by restorative proctocolectomy with partial intersphincteric resection for advanced rectal cancer associated with ulcerative colitis: report of a case.

Inoue Y, Araki T, Okugawa Y, Kawamoto A, Hiro J, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Kusunoki M.

Surg Today. 2014 Feb;44(2):387-90. doi: 10.1007/s00595-013-0558-9. Epub 2013 Mar 24. Review.

PMID:
23525639
48.

Transumbilical single-incision laparoscopic ileocecal resection for Crohn's disease in a child.

Inoue M, Uchida K, Otake K, Okigami M, Okita Y, Hiro J, Araki T, Kusunoki M.

Asian J Endosc Surg. 2013 Feb;6(1):48-51. doi: 10.1111/j.1758-5910.2012.00162.x.

PMID:
23347707
49.

Prognostic significance of opioid use in the active treatment of advanced colorectal cancer.

Inoue Y, Iwata T, Okugawa Y, Kawamoto A, Hiro J, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Kusunoki M.

Mol Clin Oncol. 2013 Jan;1(1):59-64. Epub 2012 Aug 31.

50.

Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer.

Okugawa Y, Tanaka K, Inoue Y, Kawamura M, Kawamoto A, Hiro J, Saigusa S, Toiyama Y, Ohi M, Uchida K, Mohri Y, Kusunoki M.

Br J Cancer. 2013 Jan 15;108(1):121-30. doi: 10.1038/bjc.2012.499. Epub 2012 Nov 22.

Supplemental Content

Support Center